Immunome Inc.

0 products tracked · names used in filings: Immunome Inc.

Upcoming milestones

Wed 28 Apr 2027🇺🇸 PDUFA datecompany-announcedin 165 days

Varegacestat: PDUFA target action date (desmoid tumors)

Immunome Inc. (IMNM); NDA; status: set; "…Varegacestat PDUFA target action date of April 28, 2027; Marketing Authorization Application (MAA) validated by the European Medicines Agency (EMA) • Initial IM-1021 results s"; filed 2026-11-09 · source

Recent milestones

No recent milestones.

Products

No products recorded.

Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.